Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez, D.
Right arrow Articles by Riou, J.-F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez, D.
Right arrow Articles by Riou, J.-F.
[Cancer Research 62, 3365-3368, June 15, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

Detection of Telomerase Inhibitors Based on G-Quadruplex Ligands by a Modified Telomeric Repeat Amplification Protocol Assay1

Dennis Gomez, Jean-Louis Mergny and Jean-François Riou2

Laboratoire de Physiologie Humaine, CNRS UMR 6142, UFR de Pharmacie, Université de Reims Champagne-Ardenne, 51096 Reims Cedex [D. G., J-F. R.], and Laboratoire de Biophysique, Muséum National d’Histoire Naturelle, INSERM U 565, CNRS UMR 8646, Paris [J-L. M.], France

The telomeric repeat amplification protocol (TRAP) is commonly used to evaluate telomerase activity in tissues or cell extracts and also to determine the inhibitory properties of small molecules against telomerase. The recent discovery of G-quadruplex ligands as potent telomerase inhibitors prompted us to examine the accuracy of TRAP to be used to screen such class of molecules. Because of the specific feature of the TS primer, TRAP only allows the detection of G-quadruplex-induced telomerase inhibition after the synthesis of four TTAGGG repeats by telomerase and may thus lead to misinterpretations during screening assays. We have developed a TRAP-G4 assay that will allow the unambiguous detection of the inhibitory properties of a G-quadruplex ligand on telomerase activity and is able to discriminate them from other telomerase inhibitors.




This article has been cited by other articles:


Home page
Mol Cancer ResHome page
F.-C. Huang, C.-C. Chang, P.-J. Lou, I-C. Kuo, C.-W. Chien, C.-T. Chen, F.-Y. Shieh, T.-C. Chang, and J.-J. Lin
G-Quadruplex Stabilizer 3,6-Bis(1-Methyl-4-Vinylpyridinium)Carbazole Diiodide Induces Accelerated Senescence and Inhibits Tumorigenic Properties in Cancer Cells
Mol. Cancer Res., June 1, 2008; 6(6): 955 - 964.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Machado-Pinilla, I. Sanchez-Perez, J. Ramon Murguia, L. Sastre, and R. Perona
A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells
Blood, March 1, 2008; 111(5): 2606 - 2614.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. De Cian, G. Cristofari, P. Reichenbach, E. De Lemos, D. Monchaud, M.-P. Teulade-Fichou, K. Shin-ya, L. Lacroix, J. Lingner, and J.-L. Mergny
Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action
PNAS, October 30, 2007; 104(44): 17347 - 17352.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Brassart, D. Gomez, A. D. Cian, R. Paterski, A. Montagnac, K.-H. Qui, N. Temime-Smaali, C. Trentesaux, J.-L. Mergny, F. Gueritte, et al.
A New Steroid Derivative Stabilizes G-Quadruplexes and Induces Telomere Uncapping in Human Tumor Cells
Mol. Pharmacol., September 1, 2007; 72(3): 631 - 640.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
Y. Yao, Q. Wang, Y.-h. Hao, and Z. Tan
An exonuclease I hydrolysis assay for evaluating G-quadruplex stabilization by small molecules
Nucleic Acids Res., May 14, 2007; 35(9): e68 - e68.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Enokizono, Y. Konishi, K. Nagata, K. Ouhashi, S. Uesugi, F. Ishikawa, and M. Katahira
Structure of hnRNP D Complexed with Single-stranded Telomere DNA and Unfolding of the Quadruplex by Heterogeneous Nuclear Ribonucleoprotein D
J. Biol. Chem., May 13, 2005; 280(19): 18862 - 18870.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Gomez, T. Lemarteleur, L. Lacroix, P. Mailliet, J.-L. Mergny, and J.-F. Riou
Telomerase downregulation induced by the G-quadruplex ligand 12459 in A549 cells is mediated by hTERT RNA alternative splicing
Nucleic Acids Res., January 16, 2004; 32(1): 371 - 379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Gomez, N. Aouali, A. Londono-Vallejo, L. Lacroix, F. Megnin-Chanet, T. Lemarteleur, C. Douarre, K. Shin-ya, P. Mailliet, C. Trentesaux, et al.
Resistance to the Short Term Antiproliferative Activity of the G-quadruplex Ligand 12459 Is Associated with Telomerase Overexpression and Telomere Capping Alteration
J. Biol. Chem., December 12, 2003; 278(50): 50554 - 50562.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Gomez, N. Aouali, A. Renaud, C. Douarre, K. Shin-ya, J. Tazi, S. Martinez, C. Trentesaux, H. Morjani, and J.-F. Riou
Resistance to Senescence Induction and Telomere Shortening by a G-Quadruplex Ligand Inhibitor of Telomerase
Cancer Res., October 1, 2003; 63(19): 6149 - 6153.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.